BCA
ABBV icon

Bay Colony Advisors’s AbbVie ABBV Stock Holding History

Bay Colony Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.18M Sell
8,670
-66
-0.8% -$14.2K 0.24% 86
2026
Q1 		$1.9M Buy
8,736
+475
+6% +$105K 0.23% 97
2025
Q4 		$1.89M Buy
8,261
+19
+0.2% +$4.33K 0.23% 91
2025
Q3 		$1.91M Sell
8,242
-68
-0.8% -$13.8K 0.23% 95
2025
Q2 		$1.54M Sell
8,310
-35
-0.4% -$6.5K 0.21% 97
2025
Q1 		$1.71M Sell
8,345
-2,167
-21% -$421K 0.26% 82
2024
Q4 		$1.87M Buy
10,512
+16
+0.2% +$2.94K 0.28% 76
2024
Q3 		$2.07M Sell
10,496
-5
-0% -$933 0.31% 70
2024
Q2 		$1.8M Sell
10,501
-16
-0.2% -$2.65K 0.3% 72
2024
Q1 		$1.92M Sell
10,517
-462
-4% -$79.6K 0.34% 68
2023
Q4 		$1.7M Buy
10,979
+1,642
+18% +$239K 0.33% 71
2023
Q3 		$1.39M Sell
9,337
-3,705
-28% -$544K 0.33% 72
2023
Q2 		$1.76M Buy
13,042
+541
+4% +$79.3K 0.42% 61
2023
Q1 		$1.97M Sell
12,501
-612
-5% -$93.6K 0.52% 46
2022
Q4 		$2.12M Sell
13,113
-642
-5% -$98.4K 0.56% 40
2022
Q3 		$1.85M Sell
13,755
-548
-4% -$78.6K 0.55% 36
2022
Q2 		$2.05M Buy
14,303
+1,299
+10% +$198K 0.52% 40
2022
Q1 		$2.11M Sell
13,004
-3,985
-23% -$579K 0.5% 49
2021
Q4 		$2.3M Sell
16,989
-453
-3% -$53.5K 0.66% 35
2021
Q3 		$1.88M Buy
17,442
+117
+0.7% +$13.4K 0.62% 41
2021
Q2 		$1.95M Buy
17,325
+212
+1% +$23.9K 0.65% 32
2021
Q1 		$1.85M Buy
17,113
+2,569
+18% +$275K 0.71% 31
2020
Q4 		$1.56M Sell
14,544
-975
-6% -$93.7K 0.83% 22
2020
Q3 		$1.36M Buy
15,519
+470
+3% +$44.2K 0.84% 27
2020
Q2 		$1.48M Sell
15,049
-3,030
-17% -$267K 1.07% 19
2020
Q1 		$1.38M Buy
18,079
+3,799
+27% +$324K 1.25% 12
2019
Q4 		$1.25M Sell
14,280
-6,325
-31% -$525K 0.81% 24
2019
Q3 		$1.56M Buy
20,605
+16,784
+439% +$1.15M 1.06% 11
2019
Q2 		$278K Buy
+3,821
New +$300K 0.18% 156
2018
Q3 		– Sell
-990
Closed -$92K – 217
2018
Q2 		$92K Buy
+990
New +$96.7K 0.07% 263

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Bay Colony Advisors's ABBV Position: Q2 2026 in Review

Bay Colony Advisors reduced its AbbVie (ABBV) stake by 0.76% in Q2 2026, selling an estimated $14.2K and leaving 8,670 shares worth $2.18M. The position accounts for 0.24% of the portfolio, ranked #86.

Bay Colony Advisors first reported a position in ABBV in Q2 2018 and has held it in 30 quarters since. The position peaked at $2.3M in Q4 2021. 1,448 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bay Colony Advisors held 8,670 shares of AbbVie worth $2.18M as of Q2 2026.
  • Bay Colony Advisors sold 66 AbbVie shares in Q2 2026, an estimated $14.2K.
  • AbbVie made up 0.24% of Bay Colony Advisors's portfolio in Q2 2026, its #86 holding.
  • Bay Colony Advisors first reported a position in AbbVie in Q2 2018 and has held it in 30 quarters since.
  • Bay Colony Advisors's AbbVie position peaked at $2.3M in Q4 2021.
  • 1,448 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.